Edesa Biotech, Inc. (EDSA) Total Assets by Year
Edesa Biotech, Inc. closed fiscal year 2025 with $13.5M in total assets, $1.1M in total liabilities and $12.5M in shareholder equity. This represents an increase of 254.8% from the prior fiscal year. The table below carries 13 fiscal years, from 2012 to 2025, and the quarters Edesa Biotech, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
EDSA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.5M+254.8% | $3.8M-57.1% | $8.9M-23.2% | $11.6M-20.6% | $14.6M+35.5% | $10.8M | $3.4M-56.0% | $7.7M-40.3% | $12.9M+24.6% | $10.4M-30.0% | $14.8M-7.7% | $16.1M | N/A |
| Total Liabilities | $1.1M-41.2% | $1.8M-0.5% | $1.8M-15.7% | $2.2M+43.1% | $1.5M-63.1% | $4.1M | $184K-42.7% | $321K-48.5% | $624K-73.8% | $2.4M-45.4% | $4.4M-59.3% | $10.7M | N/A |
| Total Equity | $12.5M+528.5% | $2.0M-71.9% | $7.0M-24.9% | $9.4M-28.1% | $13.1M+96.9% | $6.6M | $3.2M-56.6% | $7.4M-39.9% | $12.3M+53.8% | $8.0M-23.5% | $10.5M+60.1% | $6.5M+624.6% | $902K |
EDSA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.7M-14.1% | $12.4M-24.7% | $14.7M+253.3% | $13.5M+254.8% | $14.8M+183.2% | $16.5M+154.1% | $4.2M-46.8% | $3.8M-57.1% | $5.2M-44.5% | $6.5M-39.3% | $7.8M-32.9% | $8.9M-23.2% |
| Total Liabilities | $3.9M+481.3% | $2.2M+139.2% | $756K-60.2% | $1.1M-41.2% | $673K-71.5% | $915K-57.5% | $1.9M-4.4% | $1.8M-0.5% | $2.4M+50.5% | $2.2M+28.5% | $2.0M+41.8% | $1.8M-15.7% |
| Total Equity | $8.8M-37.7% | $10.2M-34.4% | $14.0M+516.4% | $12.5M+528.5% | $14.1M+392.9% | $15.5M+259.4% | $2.3M-61.3% | $2.0M-71.9% | $2.9M-63.5% | $4.3M-52.0% | $5.8M-43.1% | $7.0M-24.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Edesa Biotech, Inc. financials
Frequently Asked Questions
What was Edesa Biotech, Inc.'s total assets in fiscal year 2025?
Edesa Biotech, Inc. closed fiscal year 2025 with $13.5M in total assets, $1.1M in total liabilities and $12.5M in shareholder equity.
How fast is Edesa Biotech, Inc.'s total assets growing?
Edesa Biotech, Inc. (EDSA) total assets rose by 254.8% year over year, from $3.8M to $13.5M in fiscal year 2025.
What was Edesa Biotech, Inc.'s total assets in the most recent quarter?
Edesa Biotech, Inc. (EDSA) reported $12.7M in total assets in Q3 2026. This represents a decrease of 14.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Edesa Biotech, Inc. (EDSA) reported on that line in every period on record.